KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Short-term Investments (2016 - 2017)

Idexx Laboratories (IDXX) has 6 years of Short-term Investments data on record, last reported at $284.3 million in Q4 2017.

  • For Q4 2017, Short-term Investments rose 19.96% year-over-year to $284.3 million; the TTM value through Dec 2017 reached $284.3 million, up 19.96%, while the annual FY2017 figure was $284.3 million, 19.96% up from the prior year.
  • Short-term Investments reached $284.3 million in Q4 2017 per IDXX's latest filing, roughly flat from $285.1 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $285.1 million in Q3 2017 and bottomed at $453000.0 in Q1 2014.
  • Average Short-term Investments over 5 years is $145.5 million, with a median of $208.4 million recorded in 2015.
  • Peak YoY movement for Short-term Investments: tumbled 90.07% in 2014, then skyrocketed 30631.79% in 2015.
  • A 5-year view of Short-term Investments shows it stood at $1.1 million in 2013, then surged by 910.47% to $10.9 million in 2014, then surged by 1859.01% to $213.6 million in 2015, then rose by 10.94% to $236.9 million in 2016, then grew by 19.96% to $284.3 million in 2017.
  • Per Business Quant database, its latest 3 readings for Short-term Investments were $284.3 million in Q4 2017, $285.1 million in Q3 2017, and $256.9 million in Q2 2017.